Pre-submission meeting with EMA has been completed
As previously announced, Double Bond Pharmaceutical has submitted an application to EMA for scientific advice, known as Protocol Assistance, for SI-053. The Protocol Assistance is given based on questions to EMA that the company prepares in advance regarding the clinical trial protocol for their product, and the quality of these questions is crucial for the outcome of the meeting in the form of value for the company and for product development. Yesterday, Double Bond Pharmaceutical had therefore a pre-submission meeting with EMA and discussed the layout of these questions, before the